These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 10401882

  • 21. Hormone replacement therapy, reproductive history, and colon cancer: a multicenter, case-control study in the United States.
    Kampman E, Potter JD, Slattery ML, Caan BJ, Edwards S.
    Cancer Causes Control; 1997 Mar; 8(2):146-58. PubMed ID: 9134238
    [Abstract] [Full Text] [Related]

  • 22. Colon cancer risk and different HRT formulations: a case-control study.
    Dinger JC, Heinemann LA, Möhner S, Thai do M, Assmann A.
    BMC Cancer; 2007 May 08; 7():76. PubMed ID: 17488513
    [Abstract] [Full Text] [Related]

  • 23. Hormone replacement therapy and risk of colon and rectal cancer.
    Fernandez E, La Vecchia C, Braga C, Talamini R, Negri E, Parazzini F, Franceschi S.
    Cancer Epidemiol Biomarkers Prev; 1998 Apr 08; 7(4):329-33. PubMed ID: 9568789
    [Abstract] [Full Text] [Related]

  • 24. Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).
    Hulley S, Furberg C, Barrett-Connor E, Cauley J, Grady D, Haskell W, Knopp R, Lowery M, Satterfield S, Schrott H, Vittinghoff E, Hunninghake D, HERS Research Group.
    JAMA; 2002 Jul 03; 288(1):58-66. PubMed ID: 12090863
    [Abstract] [Full Text] [Related]

  • 25. Estrogen and colorectal cancer incidence and mortality.
    Lavasani S, Chlebowski RT, Prentice RL, Kato I, Wactawski-Wende J, Johnson KC, Young A, Rodabough R, Hubbell FA, Mahinbakht A, Simon MS.
    Cancer; 2015 Sep 15; 121(18):3261-71. PubMed ID: 26036212
    [Abstract] [Full Text] [Related]

  • 26. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial.
    Cauley JA, Robbins J, Chen Z, Cummings SR, Jackson RD, LaCroix AZ, LeBoff M, Lewis CE, McGowan J, Neuner J, Pettinger M, Stefanick ML, Wactawski-Wende J, Watts NB, Women's Health Initiative Investigators.
    JAMA; 2003 Oct 01; 290(13):1729-38. PubMed ID: 14519707
    [Abstract] [Full Text] [Related]

  • 27. Postmenopausal hormone replacement therapy: scientific review.
    Nelson HD, Humphrey LL, Nygren P, Teutsch SM, Allan JD.
    JAMA; 2002 Aug 21; 288(7):872-81. PubMed ID: 12186605
    [Abstract] [Full Text] [Related]

  • 28. Esterified estrogen and conjugated equine estrogen and the risk of incident myocardial infarction and stroke.
    Lemaitre RN, Weiss NS, Smith NL, Psaty BM, Lumley T, Larson EB, Heckbert SR.
    Arch Intern Med; 2006 Feb 27; 166(4):399-404. PubMed ID: 16505258
    [Abstract] [Full Text] [Related]

  • 29. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).
    Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M, Hsia J, Hulley S, Herd A, Khan S, Newby LK, Waters D, Vittinghoff E, Wenger N, HERS Research Group.
    JAMA; 2002 Jul 03; 288(1):49-57. PubMed ID: 12090862
    [Abstract] [Full Text] [Related]

  • 30. Continuation of postmenopausal hormone replacement therapy in a large health maintenance organization: transdermal matrix patch versus oral estrogen therapy.
    Ettinger B, Pressman A.
    Am J Manag Care; 1999 Jun 03; 5(6):779-85. PubMed ID: 10538456
    [Abstract] [Full Text] [Related]

  • 31. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec 03; 15(6):453-65. PubMed ID: 11826770
    [Abstract] [Full Text] [Related]

  • 32. Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial.
    Anderson GL, Judd HL, Kaunitz AM, Barad DH, Beresford SA, Pettinger M, Liu J, McNeeley SG, Lopez AM, Women's Health Initiative Investigators.
    JAMA; 2003 Oct 01; 290(13):1739-48. PubMed ID: 14519708
    [Abstract] [Full Text] [Related]

  • 33. Estrogen replacement therapy and endometrial cancer risk: unresolved issues. The Endometrial Cancer Collaborative Group.
    Brinton LA, Hoover RN.
    Obstet Gynecol; 1993 Feb 01; 81(2):265-71. PubMed ID: 8380913
    [Abstract] [Full Text] [Related]

  • 34. Risk of endometrial cancer following estrogen replacement with and without progestins.
    Weiderpass E, Adami HO, Baron JA, Magnusson C, Bergström R, Lindgren A, Correia N, Persson I.
    J Natl Cancer Inst; 1999 Jul 07; 91(13):1131-7. PubMed ID: 10393721
    [Abstract] [Full Text] [Related]

  • 35. Effect of estrogen receptor-alpha (ESR1) gene polymorphism on high density lipoprotein levels in response to hormone replacement therapy.
    Nogueira-de-Souza NC, Guerreiro da Silva ID, Carvalho CV, Pulchinelli A, Haidar MA, Baracat EC, Massad-Costa AM.
    Braz J Med Biol Res; 2009 Dec 07; 42(12):1138-42. PubMed ID: 19936541
    [Abstract] [Full Text] [Related]

  • 36. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial.
    Buyon JP, Petri MA, Kim MY, Kalunian KC, Grossman J, Hahn BH, Merrill JT, Sammaritano L, Lockshin M, Alarcón GS, Manzi S, Belmont HM, Askanase AD, Sigler L, Dooley MA, Von Feldt J, McCune WJ, Friedman A, Wachs J, Cronin M, Hearth-Holmes M, Tan M, Licciardi F.
    Ann Intern Med; 2005 Jun 21; 142(12 Pt 1):953-62. PubMed ID: 15968009
    [Abstract] [Full Text] [Related]

  • 37. Etidronate and hormone replacement therapy (HRT) for postmenopausal women with osteoporosis despite HRT.
    Morishige K, Yamamoto T, Sawada K, Ohmichi M, Tasaka K, Murata Y.
    Arch Gynecol Obstet; 2003 Jun 21; 268(2):105-6. PubMed ID: 12768299
    [Abstract] [Full Text] [Related]

  • 38. Defining hormone replacement therapy in longitudinal studies: impact on measures of effect.
    Csizmadi I, Collet JP, Benedetti A, Boivin JF, Hanley JA.
    Pharmacoepidemiol Drug Saf; 2004 Apr 21; 13(4):215-25. PubMed ID: 15255088
    [Abstract] [Full Text] [Related]

  • 39. The oxidative metabolism of estrogen modulates response to ERT/HRT in postmenopausal women.
    Armamento-Villareal RC, Napoli N, Klug T, Civitelli R.
    Bone; 2004 Sep 21; 35(3):682-8. PubMed ID: 15336604
    [Abstract] [Full Text] [Related]

  • 40. Symptom relief and side effects of postmenopausal hormones: results from the Postmenopausal Estrogen/Progestin Interventions Trial.
    Greendale GA, Reboussin BA, Hogan P, Barnabei VM, Shumaker S, Johnson S, Barrett-Connor E.
    Obstet Gynecol; 1998 Dec 21; 92(6):982-8. PubMed ID: 9840563
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.